The current diagnostic work-up of PCa involves prostate-specific antigen (PSA) testing and magnetic resonance imaging (MRI) scanning, however, screening for PCa has proven unsuccessful due to the non-specific nature of PSA4,5. This evidence concerns the gene KLK3 and posterior cortical atrophy.